SLC28A1

solute carrier family 28 member 1, the group of Solute carrier family 28

Basic information

Region (hg38): 15:84884654-84945798

Links

ENSG00000156222NCBI:9154OMIM:606207HGNC:11001Uniprot:O00337AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Uridine-cytidineuriaARGeneralThe clinical relevance is unclearBiochemical30658162; 30847922

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC28A1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC28A1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
7
clinvar
9
missense
36
clinvar
2
clinvar
7
clinvar
45
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
3
3
non coding
1
clinvar
2
clinvar
3
Total 0 0 37 5 17

Variants in SLC28A1

This is a list of pathogenic ClinVar variants found in the SLC28A1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-84887769-C-T SLC28A1-related disorder Benign (Apr 10, 2018)776941
15-84887830-A-C not specified Uncertain significance (Mar 23, 2022)2279720
15-84887831-T-A not specified Uncertain significance (Mar 23, 2022)2279721
15-84888762-C-T SLC28A1-related disorder Likely benign (Dec 26, 2019)3056473
15-84888799-T-C SLC28A1-related disorder Benign (Nov 08, 2019)3042333
15-84888803-G-A SLC28A1-related disorder Benign (Nov 13, 2019)3043971
15-84888842-C-G not specified Uncertain significance (Jan 02, 2024)3164011
15-84888842-C-T not specified Uncertain significance (Feb 21, 2024)3164012
15-84890532-C-T not specified Uncertain significance (Apr 18, 2024)3319400
15-84894964-C-T not specified Uncertain significance (Dec 07, 2023)3164015
15-84894993-G-A not specified Uncertain significance (Oct 06, 2021)2253989
15-84895038-C-T not specified Uncertain significance (Nov 09, 2021)2259702
15-84895048-A-C not specified Uncertain significance (Mar 24, 2023)2524593
15-84895080-C-CTTG SLC28A1-related disorder Benign (Oct 30, 2019)3060075
15-84895099-C-T not specified Uncertain significance (May 07, 2024)3319396
15-84895102-G-A SLC28A1-related disorder Likely benign (Jan 01, 2023)2645652
15-84895110-C-A not specified Uncertain significance (Aug 13, 2021)2244136
15-84895420-C-G SLC28A1-related disorder Likely benign (Nov 25, 2019)3048865
15-84904099-G-T not specified Uncertain significance (Jan 16, 2024)3164017
15-84904147-A-G not specified Uncertain significance (Nov 07, 2023)3164018
15-84904159-G-A not specified Uncertain significance (Apr 16, 2024)3319399
15-84904200-G-A SLC28A1-related disorder Benign (Oct 30, 2019)3059692
15-84904203-G-T SLC28A1-related disorder Benign (Nov 08, 2019)3041811
15-84904227-C-T not specified Uncertain significance (May 03, 2023)2542721
15-84904236-G-A not specified Uncertain significance (May 11, 2022)2375988

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC28A1protein_codingprotein_codingENST00000394573 1790992
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.74e-200.0060712534324031257480.00161
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.7423933541.110.00002244184
Missense in Polyphen136138.770.980041740
Synonymous-1.651771511.170.00001051331
Loss of Function0.3893133.40.9270.00000174361

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.01500.0149
Ashkenazi Jewish0.0009920.000993
East Asian0.0002170.000217
Finnish0.0001010.0000924
European (Non-Finnish)0.0004060.000404
Middle Eastern0.0002170.000217
South Asian0.002420.00242
Other0.001300.00130

dbNSFP

Source: dbNSFP

Function
FUNCTION: Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective inhibition: adenosine, thymidine, cytidine, uridine >> guanosine, inosine.;
Pathway
Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics;Gemcitabine Pathway, Pharmacodynamics;Capecitabine Action Pathway;Capecitabine Metabolism Pathway;Gemcitabine Action Pathway;Gemcitabine Metabolism Pathway;Purine metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Pyrimidine metabolism;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane (Consensus)

Recessive Scores

pRec
0.171

Intolerance Scores

loftool
0.876
rvis_EVS
0.76
rvis_percentile_EVS
86.85

Haploinsufficiency Scores

pHI
0.0673
hipred
N
hipred_score
0.154
ghis
0.411

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.247

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Slc28a1
Phenotype

Gene ontology

Biological process
nucleobase-containing compound metabolic process;pyrimidine nucleobase transport;nucleoside transport;pyrimidine-containing compound transmembrane transport;nucleoside transmembrane transport;purine nucleobase transmembrane transport
Cellular component
plasma membrane;integral component of plasma membrane;membrane
Molecular function
nucleoside transmembrane transporter activity;nucleoside:sodium symporter activity;pyrimidine- and adenine-specific:sodium symporter activity